Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
Follow DHR
Danaher Corporation (DHR) Return on assets
Danaher Corporation's return on assets over the twelve months to 30 June 2026 was 4.60%, up 0.1 percentage points from fiscal 2025 (4.49%). Over the past ten years it has ranged from 4.49% (fiscal 2025) to 8.48% (fiscal 2022) — the current reading is the lowest in ten years. That is above the Diagnostics & Research industry median of −6.71% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 4.49% | (0.32) |
| FY2024 | 4.81% | (0.81) |
| FY2023 | 5.62% | (2.86) |
| FY2022 | 8.48% | 0.61 |
| FY2021 | 7.87% | 2.79 |
| FY2020 | 5.08% | (0.27) |
| FY2019 | 5.35% | (0.26) |
| FY2018 | 5.61% | 0.19 |
| FY2017 | 5.42% | (0.04) |
| FY2016 | 5.46% | (2.42) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 33.7% |
| MTD Mettler-Toledo International, Inc. compare | 25.6% |
| ILMN Illumina, Inc. compare | 13.0% |
| A Agilent Technologies, Inc. compare | 11.0% |
| TMO Thermo Fisher Scientific Inc. compare | 6.50% |
| IQV IQVIA Holdings Inc. compare | 4.70% |
| DHR Danaher Corporation | 4.60% |
| WAT Waters Corporation compare | 1.13% |
| NTRA Natera, Inc. compare | −8.71% |
| Diagnostics & Research industry median | −6.71% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement